John Kastelein: Exploring the Biology of Cardiovascular Disease at BioCentury Grand Rounds Europe
John Kastelein, Co-Founder and Chief Scientific Officer at NewAmsterdam Pharma, Operating Partner of Forbion Capital Management, Chief Executive Officer of Vascular Research Network B.V., Co-Founder of Dezima Pharma and UniQure, shared a post on LinkedIn:
“I recently participated in BioCentury Inc. Grand Rounds Europe in Amsterdam, where I joined colleagues to discuss how advances in vascular biology, genetics, inflammation, thrombosis, and metabolism are changing the way we understand cardiovascular disease.
These mechanisms are deeply interconnected. Understanding why they work the way they do, and how we should scientifically approach them from different points of view, may help inform the next generation of cardiovascular therapies.
That is what makes discussions like this so valuable. Progress requires us to look beyond traditional boundaries, revisit longstanding assumptions, and remain open to where the research and the data lead.
I appreciated the opportunity to learn from my fellow panelists, Peter Carmeliet, Luca Andrea Lotta, and Pieter H. Reitsma, each of whom brought a valuable perspective to the conversation.
Thank you to BioCentury and to our moderator, Vanessa Carle, for bringing us together for such a thoughtful discussion.”

Stay updated with Hemostasis Today.
-
Nov 8, 2026, 12:22Marc Carrier: Advancing Catheter-Related Thrombosis Prevention Through Factor XI Inhibition
-
Nov 8, 2026, 11:56Why Genetic Predisposition Does Not Always Lead to Thrombosis – Stork Genetics
-
Nov 8, 2026, 11:45Sher-Lu Pai: Investigating Intracardiac Thrombosis and Its Management in Liver Transplantation
-
Nov 8, 2026, 11:25Mehmet Cilingiroglu: Navigating Anticoagulation Choices in Acute Coronary Syndrome PCI
-
Nov 8, 2026, 07:16Gilberto de lima Lopes Junior: The Cardiovascular Consequences of Cancer in Younger Patients
-
Nov 8, 2026, 06:51Haney Mallemat: Key Principles and Pitfalls of LVAD Emergencies
-
Nov 8, 2026, 06:31Maria Omer: Clinical Recognition and Management of Cavernous Sinus Thrombosis
-
Nov 8, 2026, 06:16Natasha Jolakoski: University of New Mexico Hospital Promotes PGY-2 Thrombosis and Hemostasis Management Pharmacy Residency
-
Nov 8, 2026, 05:47Safaa Hilal: POCUS in the Evaluation of Perioperative Troponin Elevation